William H Craft1, Allison N Tegge2, Liqa N Athamneh3, Devin C Tomlinson1, Roberta Freitas-Lemos3, Warren K Bickel4. 1. Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA, United States; Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Roanoke, VA, United States. 2. Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA, United States; Department of Statistics, Virginia Tech, Blacksburg, VA, United States. 3. Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA, United States. 4. Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA, United States. Electronic address: wkbickel@vtc.vt.edu.
Abstract
INTRODUCTION: Substance use disorders (SUDs) remain challenging maladies to treat in the United States and impose significant societal costs. Despite these challenges, a significant number of individuals endorse being in recovery from SUD. The scientific understanding of SUD recovery has evolved to include not only improvements in substance use but also improvements in personal wellness and psychosocial functioning. The devaluation of future rewards (delay discounting; DD) is broadly associated with SUD inception and outcomes. We sought to investigate the relationship between DD, time in recovery, and recovery progress. METHODS: We conducted an online assessment of 127 individuals in recovery from SUD who the study recruited via the International Quit and Recovery Registry (IQRR). The research team obtained measures of recovery progress via the Addiction Recovery Questionnaire (ARQ) and the Treatment Effectiveness Assessment (TEA). Additionally, the study collected measures of DD, time in recovery, and endorsement of abstinence in recovery (i.e., requiring abstinence vs. not). We utilized linear regression to test for associations among these variables and performed a mediation analysis to test the role of DD in mediating the relationship between time in recovery and measures of recovery progress. RESULTS: Time in recovery was positively associated with the ARQ (p < .001) and TEA (p < .001). Furthermore, an individual's delay discounting rate mediated the relationship between time in recovery and ARQ/TEA. Of the participants, 66% endorsed recovery requiring total abstinence from alcohol and drugs. Last, through an exhaustive model selection, the study did not find an individual's endorsement of abstinence in recovery to be a primary predictor of recovery progress. CONCLUSIONS: This study presents evidence that, for individuals in recovery, the temporal view (i.e., focus on immediate vs. future rewards) is a significant influence on recovery progress. Additionally, an individual's endorsement of abstinence in recovery was not significantly associated with recovery progress, suggesting the importance of a holistic view of SUD recovery. These findings contribute to the understanding of recovery as a multidimensional process and provide further support for DD as a behavioral marker of addiction.
INTRODUCTION: Substance use disorders (SUDs) remain challenging maladies to treat in the United States and impose significant societal costs. Despite these challenges, a significant number of individuals endorse being in recovery from SUD. The scientific understanding of SUD recovery has evolved to include not only improvements in substance use but also improvements in personal wellness and psychosocial functioning. The devaluation of future rewards (delay discounting; DD) is broadly associated with SUD inception and outcomes. We sought to investigate the relationship between DD, time in recovery, and recovery progress. METHODS: We conducted an online assessment of 127 individuals in recovery from SUD who the study recruited via the International Quit and Recovery Registry (IQRR). The research team obtained measures of recovery progress via the Addiction Recovery Questionnaire (ARQ) and the Treatment Effectiveness Assessment (TEA). Additionally, the study collected measures of DD, time in recovery, and endorsement of abstinence in recovery (i.e., requiring abstinence vs. not). We utilized linear regression to test for associations among these variables and performed a mediation analysis to test the role of DD in mediating the relationship between time in recovery and measures of recovery progress. RESULTS: Time in recovery was positively associated with the ARQ (p < .001) and TEA (p < .001). Furthermore, an individual's delay discounting rate mediated the relationship between time in recovery and ARQ/TEA. Of the participants, 66% endorsed recovery requiring total abstinence from alcohol and drugs. Last, through an exhaustive model selection, the study did not find an individual's endorsement of abstinence in recovery to be a primary predictor of recovery progress. CONCLUSIONS: This study presents evidence that, for individuals in recovery, the temporal view (i.e., focus on immediate vs. future rewards) is a significant influence on recovery progress. Additionally, an individual's endorsement of abstinence in recovery was not significantly associated with recovery progress, suggesting the importance of a holistic view of SUD recovery. These findings contribute to the understanding of recovery as a multidimensional process and provide further support for DD as a behavioral marker of addiction.
Authors: Sara Domínguez-Salas; Carmen Díaz-Batanero; Oscar Martin Lozano-Rojas; Antonio Verdejo-García Journal: Neurosci Biobehav Rev Date: 2016-10-25 Impact factor: 8.989
Authors: Liqa N Athamneh; Madison D Stein; Elysia H Lin; Jeffrey S Stein; Alexandra M Mellis; Kirstin M Gatchalian; Leonard H Epstein; Warren K Bickel Journal: Exp Clin Psychopharmacol Date: 2020-03-19 Impact factor: 3.157
Authors: Henning Pettersen; Anne Landheim; Ivar Skeie; Stian Biong; Morten Brodahl; Victoria Benson; Larry Davidson Journal: Subst Abuse Date: 2018-02-07
Authors: Jeffrey S Stein; A George Wilson; Mikhail N Koffarnus; Tinuke Oluyomi Daniel; Leonard H Epstein; Warren K Bickel Journal: Psychopharmacology (Berl) Date: 2016-08-23 Impact factor: 4.530